295 related articles for article (PubMed ID: 31107888)
21. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
[TBL] [Abstract][Full Text] [Related]
22. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
[TBL] [Abstract][Full Text] [Related]
23. Analysis of somatic NF1 promoter methylation in plexiform neurofibromas and Schwann cells.
Fishbein L; Eady B; Sanek N; Muir D; Wallace MR
Cancer Genet Cytogenet; 2005 Mar; 157(2):181-6. PubMed ID: 15721644
[TBL] [Abstract][Full Text] [Related]
24. ERBB2 and ERBB3 Growth Factor Receptors, Neuregulin-1, CD44 and Ki-67 Proliferation Index in Neurofibromatosis Type 1-associated Peripheral Nerve Sheath Tumors.
Friedrich RE; Nörnberg LKN; Hagel C
Anticancer Res; 2022 May; 42(5):2327-2340. PubMed ID: 35489721
[TBL] [Abstract][Full Text] [Related]
25. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
26. Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.
Grit JL; Johnson BK; Dischinger PS; J Essenburg C; Adams M; Campbell S; Pollard K; Pratilas CA; Triche TJ; Graveel CR; Steensma MR
Epigenetics Chromatin; 2021 Jan; 14(1):7. PubMed ID: 33436083
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth.
Well L; Döbel K; Kluwe L; Bannas P; Farschtschi S; Adam G; Mautner VF; Salamon J
PLoS Genet; 2021 May; 17(5):e1009517. PubMed ID: 33951044
[TBL] [Abstract][Full Text] [Related]
28. Dual mTORC1/2 inhibition induces anti-proliferative effect in NF1-associated plexiform neurofibroma and malignant peripheral nerve sheath tumor cells.
Varin J; Poulain L; Hivelin M; Nusbaum P; Hubas A; Laurendeau I; Lantieri L; Wolkenstein P; Vidaud M; Pasmant E; Chapuis N; Parfait B
Oncotarget; 2016 Jun; 7(24):35753-35767. PubMed ID: 26840085
[TBL] [Abstract][Full Text] [Related]
29. Distinct Transcriptional Profiles in the Different Phenotypes of Neurofibroma from the Same Subject with Neurofibromatosis 1.
Wang WN; Koguchi-Yoshioka H; Nimura K; Watanabe R; Tanemura A; Fujimoto M; Wataya-Kaneda M
J Invest Dermatol; 2024 Jan; 144(1):133-141.e4. PubMed ID: 37301319
[TBL] [Abstract][Full Text] [Related]
30. Modeling tumors of the peripheral nervous system associated with Neurofibromatosis type 1: Reprogramming plexiform neurofibroma cells.
Mazuelas H; Carrió M; Serra E
Stem Cell Res; 2020 Dec; 49():102068. PubMed ID: 33160273
[TBL] [Abstract][Full Text] [Related]
31. The primacy of NF1 loss as the driver of tumorigenesis in neurofibromatosis type 1-associated plexiform neurofibromas.
Pemov A; Li H; Patidar R; Hansen NF; Sindiri S; Hartley SW; Wei JS; Elkahloun A; Chandrasekharappa SC; ; Boland JF; Bass S; ; Mullikin JC; Khan J; Widemann BC; Wallace MR; Stewart DR
Oncogene; 2017 Jun; 36(22):3168-3177. PubMed ID: 28068329
[TBL] [Abstract][Full Text] [Related]
32. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
33. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
34. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
[TBL] [Abstract][Full Text] [Related]
35. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.
Friedrich RE; Keiner D; Hagel C
Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826
[TBL] [Abstract][Full Text] [Related]
36. Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.
Wu J; Williams JP; Rizvi TA; Kordich JJ; Witte D; Meijer D; Stemmer-Rachamimov AO; Cancelas JA; Ratner N
Cancer Cell; 2008 Feb; 13(2):105-16. PubMed ID: 18242511
[TBL] [Abstract][Full Text] [Related]
37. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors.
Wallace MR; Rasmussen SA; Lim IT; Gray BA; Zori RT; Muir D
Genes Chromosomes Cancer; 2000 Feb; 27(2):117-23. PubMed ID: 10612798
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1.
Jiang C; McKay RM; Lee SY; Romo CG; Blakeley JO; Haniffa M; Serra E; Steensma MR; Largaespada D; Le LQ
J Invest Dermatol; 2023 Aug; 143(8):1369-1377. PubMed ID: 37318402
[TBL] [Abstract][Full Text] [Related]
39. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
40. Occult neurofibroma and increased S100 protein in the skin of patients with neurofibromatosis type 1: new insight to the etiopathomechanism of neurofibromas.
Karvonen SL; Kallioinen M; Ylä-Outinen H; Pöyhönen M; Oikarinen A; Peltonen J
Arch Dermatol; 2000 Oct; 136(10):1207-9. PubMed ID: 11030766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
